Dr. Chavez Velazquez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 S Zarzamora St
San Antonio, TX 78207Phone+1 210-358-7000Fax+1 210-358-7406
Summary
- Dr. Alberto Chavez Velazquez is an endocrinologist in San Antonio, TX and is affiliated with University Health System. He received his medical degree from Autonomous University of Tamaulipas and has been in practice 19 years. He specializes in diabetes, lipid metabolism, and thyroid.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2013 - 2015- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2011 - 2013
- The University of Texas Health Science Center at San AntonioPost-Doctoral Fellowship, 2005 - 2011
University of Texas Health Science Center at San Antonio MSCI, Clinical Investigation , 2007 - 2009- Auto Univ Tamaulipas- Fac MedClass of 1998, MD, Valedictorian
Certifications & Licensure
TX State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Type 2 Diabetes Patients: A Pilot Study.Gozde Baskoy, Richard Peterson, Jason Kempenich, Curtis Triplitt, Marissa Brown
The Journal of Clinical Endocrinology and Metabolism. 2024-12-17 - 13 citationsThe Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in HumansJuan Pablo Palavicini, Alberto Chavez-Velazquez, Marcel Fourcaudot, Devjit Tripathy, Meixia Pan
Frontiers in Physiology. 2021-01-01 - 138 citationsDapagliflozin lowers plasma glucose concentration and improves β-cell functionAurora Merovci, Andrea Mari, Carolina Solis, Juan Xiong, Giuseppe Daniele
The Journal of Clinical Endocrinology and Metabolism. 2015-02-24
Lectures
- Effect of Lowering Plasma Glucose and FFA Concentrations on Insulin Sensitivity and Beta-Cell Function in T2DM IndividualsSan Antonio, TX - 6/14/2014
- Plasma Betatrophin Levels Are Not Influenced by Acute Elevation of Free Fatty Acids and Hyperinsulinemia in Healthy IndividualsSan Antonio, TX - 6/15/2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
